Skip to main content
Caplight Logo









Benchling

Benchling

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.benchling.com

Last Round

Series F

Nov 17, 2021

Est. Valuation

$6.1B

Total Funding Raised

$405.05M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Benchling is a life sciences company that provides a lab collaboration platform to enhance the speed and collaboration of research through a suite of integrated applications for designing, sharing, and recording experiments, as well as managing DNA-sequence data in the cloud.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Vertical SaaS, Drug Discovery, Workflow Automation

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting, Freemium

AI Layer

Application

Keywords

R&D cloudlife sciences platformelectronic lab notebookELNR&D informaticsbiotech softwareLIMSscientific data platformAI-ready datadrug discovery softwarelab inventory managementmolecular biology softwareGxP compliancevalidated cloudfreemium SaaSPLG

Price History

Caplight MarketPrice™ estimate for Benchling, published with a 90-day delay.

Delayed data

Caplight MarketPrice™

$9.91

per share, as of December 2025

+0.7%

2-year change

The most recent months of MarketPrice™ are available to Caplight clients.

Caplight MarketPrice™ is an estimate of private secondary market pricing, shown here on a delayed basis for illustrative purposes only. It may be incomplete, is subject to change, and may not be relied upon for any purpose or considered investment advice.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Benchling Comparables

Compare Benchling with similar companies based on industry and business-model similarity.

Benchling comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Siemens
86%
Sapio Sciences
84%
Cenevo
81%

Benchling Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series FNov 17, 2021
Series EApr 14, 2021
Series DMay 28, 2020
Series CJul 24, 2019
Series BJun 14, 2018
VC Round
Oct 24, 2016

Key People

Founding team and executive leadership

Sajith Wickramasekara

Founder & CEO

Founding Team

Benchling Investors

Notable investors and investment history

Benchling investors
InvestorRounds
Andreessen HorowitzVC Round, Series C, Series A
Human CapitalSeries F
Benchmark CapitalSeries E, Series D, Series C
SV AngelSeed, Series A, Accelerator
ICONIQ CapitalSeries E, Series D
F-Prime CapitalSeries C, Series B
Founders FundSeed, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 30, 2026

    Integrated with Seqera Labs and Amazon S3 for R&D lifecycle management.

  • Apr 27, 2026

    Integration to expose ClinicalTrials.gov as a trusted scientific data source.

Recent news

Latest coverage and updates

  • launchesSep 19, 2026

    Benchling, Inc. launched API suite on Jul 1st '24.

  • launchesAug 20, 2026

    Benchling, Inc. launched Reactions on Aug 20th '26.

  • integrates_withAug 17, 2026

    Benchling, Inc. integrated with Kyowa Kirin Co., Ltd. on Aug 16th '26.

  • recognized_asJul 29, 2026

    Benchling, Inc. recognized as finalist in the category at 2026 Fierce AI Innovation Awards.

Benchling Filings

Explore SEC and related filing metadata, where available.

Benchling filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Appears On

Curated lists and screens where this company is featured.

Frequently Asked Questions

Common questions about Benchling's valuation, stock price, and market status.

Is Benchling a public or private company?

Benchling is a private company.

What is the current stock price of Benchling?

Benchling is a private company with no public stock price. Caplight tracks Benchling's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Benchling worth (valuation)?

Benchling's valuation is estimated at $6.1B based on funding round data.

Can I buy Benchling stock?

Benchling shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Benchling's last funding round?

Benchling's most recent funding round was Series F on November 17, 2021.

Who are the main investors in Benchling?

Key investors in Benchling include Andreessen Horowitz, Thrive Capital, Franklin Templeton Digital Assets, Draper Associates, Y Combinator.

Will Benchling IPO soon?

No public IPO plans have been announced for Benchling.

How can I track Benchling secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Benchling's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range667
Year Founded2012
Last FundingNov 17, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?